REGENXBIO presented positive initial data from the ongoing Phase II ALTITUDE trial of RGX-314 for the treatment of diabetic retinopathy (DR) without center-involved diabetic macular…
Launched in 2011 with the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) grant funds, the Washington University in St. Louis Center for…
University of Nevada, Las Vegas (UNLV) neuroscientists report on study findings purportedly strengthening the link between Type 2 diabetes and Alzheimer’s disease. With findings published…
Led by Sadiya S. Kahn, MD, MSc Division of Cardiology, a handful of physician and public health researchers from Northwestern University Medicine in Chicago A…
The Scripps Whittier Diabetes Institute received $3.1 million recently via a grant from the National Institutes of Health (NIH) for a study centering on the…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
